Abstract
Patients who have pulmonary disorders, especially those with chronic obstructive pulmonary disease, often have atrial and ventricular arrhythmias. However, the pathogenesis of these arrhythmias is complex and may involve many factors. For example, these individuals often have anatomic cardiac abnormalities, such as right ventricular hypertrophy, with or without associated congestive heart failure. Cigarette smoking is protean in patients with chronic obstructive pulmonary disease, and, consequently, atherosclerotic heart disease may be present with its attendant complications. Hypoxia and hypercapnia occur in these patients and, under appropriate circumstances, can be arrhythmogenic. Patients may receive drugs that can cause arrhythmias. For example, diuretics may lead to hypokalemia, and aminophylline and adrenergic bronchodilator drugs may create the environment necessary for arrhythmias to emerge. Finally, patients with pulmonary disease are prone to any arrhythmias that occur in other people, for example, atrioventricular nodal reentry and Wolff-Parkinson-White reentry.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Daly M, Angell-James JE, Elsner R. Role of carotid-body chemoreceptors and their reflex interactions in bradycardia and cardiac arrest. Lancet 1: 764–767, 1979.
Guilleminault C, Connally SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 52: 490–494, 1983.
Zwillich C, Devlin T, White D, Douglas N, Weil J, Martin R. Bradycardia during sleep apnea—characteristics and mechanism. J Clin Invest 69: 1286–1292, 1982.
Coleridge JCG, Coleridge HM. Chemoreflex regulation of the heart. In Handbook of Physiology, Section 2: The Cardiovascular System, Berne RM, Sperelakis N, Geiger SR (eds). Bethesda, Md: American Physiological Society, 1979, pp. 653–676.
Korner PI. Central nervous control of autonomic cardiovascular function. In Handbook of Physiology, Section 2: The Cardiovascular System, Berne RM, Sperelakis N, Geiger SR (eds). Bethesda, Md: American Physiological Society, 1979, pp. 691–739.
Samuelsson R. Effects of severe systemic hypoxia on myocardial excitation. Acta Physiol Scand 88: 267–280, 1973.
Prystowsky EN, Jackman WM, Rinkenberger RL, Heger JJ, Zipes DP. Effect of autonomic blockade on ventricular refractoriness and atrioventricular nodal conduction in man. Evidence supporting a direct cholinergic action on ventricular muscle refractoriness. Circ Res 49: 511–518, 1981.
Prystowsky EN, Naccarelli GV, Jackman WM, Rinkenberger RL, Heger JJ, Zipes DP. Enhanced parasympathetic tone shortens atrial refractoriness in man. Am J Cardiol 51: 96–100, 1983.
Hall RE, Rubinstein EH, Sonnenschein RR. Abolition of hypoxic vagal bradycardia by lateral mesencephalic lesions in spinal cats. Am J Physiol 237: R15–R19, 1979.
Senges J, Mizutani T, Pelzer D, Brachmann J, Sonnhof U, Kubler W. Effect of hypoxia on the sinoatrial node, atrium, and atrioventricular node in the rabbit heart. Circ Res 44: 856–863, 1979.
Kohlhardt M, Haap K. The influence of hypoxia and metabolic inhibitors on the excitation process in atrioventricular node. Basic Res Cardiol 75: 712–727, 1980.
Belardinelli L, Belloni FL, Rubio R, Berne RM. Atrioventricular conduction disturbances during hypoxia—Possible role of adenosine in rabbit and guinea pig heart. Circ Res 47: 684–691, 1980.
Rogers RM, Spear JF, Moore EN, Horowitz LH, Sonne JE. Vulnerability of canine ventricle to fibrillation during hypoxia and respiratory acidosis. Chest 63: 986–994, 1973.
Murnaghan MF. The effect of anoxia on the ventricular fibrillation threshold in the rabit isolated heart. Br J Pharmacol 54: 413–420. 1975.
Mauck HP, Szumski AJ, Fu TC, Forbes JE, Clendenin MA. The effect of acute hypoxia on cardiac dysrhythmias induced by mesencephalic stimulation. Am Heart J 87: 197–202, 1974.
Mauck HP Jr, Szumski AJ, Forbes JE, Clendenin MA, Newton RA. Effects of hypercapnea and of hypercapnea in combination with hypoxia on midbrain-induced cardiac dysrhythmias. Am Heart J 92: 315–323, 1976.
Steele P, Ellis JH, Van Dyke D, Sutton F, Creagh E, Davies H. Left ventricular ejection fraction in severe chronic obstructive airways disease. Am J Med 59: 21–28. 1975.
Kachel RG. Coronary arterial disease and arrhythmias in chronic obstructive lung disease. Chest 76: 242, 1979.
Holford FD, Mithoefer JC. Cardiac arrhythmias in hospitalized patients with chronic obstructive pulmonary disease. Am Rev Respir His 108: 879–885, 1973.
Biggs FD, Lefrak SS, Kleiger RE, Senior RM, Oliver GC. Disturbances of rhythm in chronic lung disease. Heart Lung 6: 256–261, 1977.
Kleiger RE, Senior RM. Long-term electrocardiographic monitoring of ambulatory patients with chronic airway obstruction. Chest 65: 483–487, 1974.
Goldberg LM, Bristow JD, Parker BM, et al. Paroxysmal atrial tachycardia with atrioventricular block. Its frequent association with chronic pulmonary disease. Circulation 21: 499, 1960.
Diener CF, Burrows B. Further observations on the course and prognosis of chronic obstructive lung disease. Am Rev Respir Dis III: 719–724, 1975.
Khokhar N. Cardiac arrhythmias associated with acute respiratory failure in chronic obstructive pulmonary disease. Milit Med 146: 856–858. 1981.
Hudson LD, Kurt TL, Petty TL, Genton E. Arrhythmias associated with acute respiratory failure in patients with chronic airway disease. Chest 63: 661–665, 1973.
Shine KI, Kastor JA, Yurchak PM. Multifocal atrial tachycardia. Clinical and electrocardiographic features in 32 patients. N Engl J Med 279: 344–349, 1968.
Phillips J, Spano J, Burch G. Chaotic atrial mechanism. Am Heart J 78: 171–179, 1969.
Lipson MJ, Naimi S: Multifocal atrial tachycardia (chaotic atrial tachycardia). Circulation 42: 397–407, 1970.
Crompton GK, Grant IWB. Observations on the management of acute bronchial asthma. Br J Dis Chest 73: 157–163, 1979.
Grossman J. The occurrence of arrhythmias in hospitalized asthmatic patients. J Allergy Clin Immunol 57: 310–317, 1976.
Josephson GW, Kennedy HL, MacKenzie EJ, Gibson G. Cardiac arrhythmias during the treatment of acute asthma. A comparison of two treatment regimens by a double blind protocol. Chest 78: 429–435, 1980.
Assael R, Martt JM, Okeson GC. Frequency of isoproterenol hydrochloride-induced cardiac arrhythmia in 19 patients with chronic obstructive pulmonary disease: A prospective study. Am Rev Respir Dis 111: 743–747, 1975.
Stolley PD. Asthma mortality. Why the United States was spared an epidemic of deaths due to asthma. Am Rev Respir Dis 105: 883–885, 1972.
Johnson JC, Flowers NC, Horan LG. Unexplained atrial flutter: A frequent herald of pulmonary embolism. Chest 60: 29–34, 1971.
Brown AK, Newton P, Hamilton EAG, Anderson V. Recurrent pulmonary thromboembolism presenting with cardiac arrhythmias. Thorax 34: 380–383, 1979.
Kanemoco N, Sasamoto H. Arrhythmias in primary pulmonary hypertension. Jpn Heart J 20: 765–775, 1979.
Osborn JJ, Raison JCA, Beaumont JO, Hill JD, Kerth WJ, Popper RW, Gerbode F. Respiratory causes of “sudden unexplained arrhythmia” in postthoracotomy patients. Surgery 69: 24–28, 1971.
Washerman K. Cardiovascular manifestations of respiratory insufficiency. Clin Notes Respir Dis 12: 3–10, 1973.
Rinkenberger RL, Prystowsky EN, Heger JJ, Troup PJ, Jackman WM, Zipes DP. Effect of IV and chronic oral verapamil administration in patients with a variety of supraventricular tachyarrhythmias. Circulation 62: 996–1010, 1980.
Klein GJ, Gulamhusein S, Prystowsky EN, Carruthers SG, Donner AP, Ko PT. Comparison of the electrophysiological effects of intravenous and oral verapamil in patients with paroxysmal supraventricular tachycardia. Am J Cardiol 49: 117–124, 1982.
Green LJ, Smith TW. The use of digitalis in patients with pulmonary disease. Ann Intern Med 87: 459–465, 1977.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishing
About this chapter
Cite this chapter
Prystowsky, E.N., Klein, G.J. (1984). Arrhythmias in Chronic Lung Disease. In: Rubin, L.J. (eds) Pulmonary Heart Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2847-6_10
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2847-6_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9797-0
Online ISBN: 978-1-4613-2847-6
eBook Packages: Springer Book Archive